CBD for CLN2 disease [dataset]

Description

This dataset provides supporting data for the manuscript titled "Chronic oral cannabidiol delays or prevents seizures in a mouse model of CLN2 disease" and is deposited to comply with PLOS One data availability requirements. The data shows that chronic treatment with cannabidiol confers significant anti-seizure benefit to the mouse model of CLN2 disease, and that it does not appear to do so by altering the inflammatory and neuroimmune markers traditionally used to track CLN2 disease progression. There are four files corresponding to Figures 1 to 3 and Table S1.

Steps to reproduce

Refer to the Methods section of the open-access manuscript.

Institutions

• Washington University in St. Louis

  Missouri, St Louis

Categories

Funders

• Lehrman Family Fund
• Batten Disease Support and Research Association

  United States

Additional Metadata for Digital Commons Data@Becker

Related Links

Licence